# Outcomes of Watch-and-Wait Versus Abdominoperineal Resection in Lower Rectal Adenocarcinoma Post Neoadjuvant Therapy: An Iraqi Cohort Study

**Authors:** Aqeel S Mahmood, Osama Jalal Fakhir, Haider A Ahmed, Manwar Abdulelah Alnaqqash, Tahseen Alrubaei, Wieeam Abdulfattah Saleh, Ahmed A Alkadir, Ahmed Zuhair Alsammarraie, Forat Yahya Mohsin, Ahmed A Shakir, Yesor Jamal Albadri, Mustafa Ismail

PMC · DOI: 10.7759/cureus.67955 · 2024-08-27

## TL;DR

This study compares watch-and-wait versus surgery for rectal cancer after successful initial treatment and finds similar outcomes in recurrence rates.

## Contribution

The study provides evidence supporting watch-and-wait as a viable alternative to surgery in select rectal cancer patients post neoadjuvant therapy.

## Key findings

- No significant difference in non-regrowth disease-free survival between watch-and-wait and surgery groups.
- Baseline T stage and CEA levels were significant predictors of locoregional failure.
- Watch-and-wait avoided surgery and stoma without increasing recurrence risk.

## Abstract

Background: Rectal malignancy ranks among the most prevalent malignancies in humans. Neoadjuvant chemoradiotherapy (nCRT) is advocated as the standard treatment for locally advanced rectal cancer. In patients who achieve complete clinical response (cCR), successive surgical intervention may result in favorable immediate and long-lasting results; however, it may be associated with decreased quality of life. This study aims to evaluate the incidence of local recurrence in rectal adenocarcinoma between patients who underwent a watch-and-wait approach and those who underwent abdominoperineal resection following the achievement of a cCR after nCRT.

Methods: This is an analytic cohort study that included 68 patients and was conducted in Baghdad Teaching Hospital/Medical City, Baghdad. The data were collected from the 1st of April 2021 to the 1st of October 2023. All patients with stage II and III rectal adenocarcinoma who achieved cCR after receiving nCRT were included in the study.

Results: There was no statistically significant difference between the two study groups regarding non-regrowth disease-free survival (p-value = 0.708). Cox-regression multivariate analysis revealed that baseline T stage and serum carcinoembryonic antigen (CEA) were significantly associated with locoregional failure.

Conclusion: The present study reveals that implementing the watch-and-wait strategy had the benefit of avoiding major surgery, stoma, and their complications without coming at the cost of reduced locoregional recurrence.

## Linked entities

- **Diseases:** rectal adenocarcinoma (MONDO:0002169)

## Full-text entities

- **Genes:** CEACAM3 (CEA cell adhesion molecule 3) [NCBI Gene 1084] {aka CD66D, CEA, CGM1, CGM1a, W264, W282}
- **Diseases:** Rectal Adenocarcinoma (MESH:D000230), locoregional failure (MESH:D051437), malignancies (MESH:D009369), Rectal malignancy (MESH:D012004)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11426549/full.md

---
Source: https://tomesphere.com/paper/PMC11426549